Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,998
Closed -$42K 67
2023
Q1
$42K Hold
28,998
0.01% 73
2022
Q4
$38.4K Hold
28,998
0.01% 75
2022
Q3
$37K Buy
28,998
+23,713
+449% +$37.5K 0.01% 81
2022
Q2
$11K Buy
+5,285
New +$16K ﹤0.01% 75

Other funds holding ADAG

Cannell Capital's ADAG Position: Q2 2023 in Review

Cannell Capital sold out of Adagene (ADAG) in Q2 2023, closing a stake of 28,998 shares — an estimated $42K sold.

Cannell Capital first reported a position in ADAG in Q2 2022 and held it in 4 quarters. The position peaked at $42K in Q1 2023. 10 funds tracked by Wall St. Rank hold ADAG as of Q2 2023.

  • Cannell Capital reported no remaining Adagene position as of Q2 2023 after selling out during the quarter.
  • Cannell Capital sold 28,998 Adagene shares in Q2 2023, an estimated $42K.
  • Cannell Capital first reported a position in Adagene in Q2 2022 and held it in 4 quarters.
  • Cannell Capital's Adagene position peaked at $42K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Adagene as of Q2 2023.

Based on Cannell Capital's 13F filing for Q2 2023, filed 14 Aug 2023.